Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Operating activities
Consolidated net income	$ 78.5	$ 64.2
Adjustments to reconcile consolidated net income to net cash flows from operating activities:
Depreciation and amortization	47.3	47.2
Deferred income taxes	(6.9)	(7.5)
Stock-based compensation expense	9.1	11.4
Provision for bad debt	2.5	1.4
Equity in investments of unconsolidated entities	2.6	1.5
Other, net	(1.1)	(11.0)
Changes in operating assets and liabilities:
Accounts receivable	17.3	13.7
Accounts payable and accrued liabilities	0.2	(4.3)
Accrued compensation and deferred commissions	(120.5)	(79.2)
Income taxes, current	20.1	16.3
Deferred revenue	47.9	50.0
Other assets and liabilities	(6.0)	(10.1)
Cash provided by operating activities	91.0	93.6
Investing activities
Purchases of investment securities	(3.3)	(7.2)
Proceeds from maturities and sales of investment securities	4.5	17.4
Capital expenditures	(32.2)	(34.1)
Acquisitions, net of cash acquired	(38.5)	0.0
Purchases of investments in unconsolidated entities	(1.2)	(2.8)
Cash used for investing activities	(70.7)	(26.7)
Financing activities
Common shares repurchased	(109.6)	0.0
Dividends paid	(19.5)	(17.3)
Proceeds from revolving credit facility	145.0	90.0
Repayment of revolving credit facility	(40.0)	(105.0)
Repayment of term facility	0.0	(8.1)
Employee taxes withheld for stock awards	0.0	(3.2)
Other, net	0.0	0.1
Cash used for financing activities	(24.1)	(43.5)
Effect of exchange rate changes on cash and cash equivalents	12.6	(7.6)
Net increase in cash and cash equivalents	8.8	15.8
Cash and cash equivalents—beginning of period	502.7	337.9
Cash and cash equivalents—end of period	511.5	353.7
Supplemental disclosure of cash flow information
Cash paid for income taxes	14.2	12.5
Cash paid for interest	$ 6.4	$ 11.5